Inhibitors of advanced glycation end product-associated protein cross-linking

被引:33
|
作者
Lehman, TD [1 ]
Ortwerth, BJ [1 ]
机构
[1] Univ Missouri, Sch Med, Mason Eye Inst, Columbia, MO 65212 USA
关键词
glycation; protein cross-linking; L-threose; advanced glycation end product; cataract; reducing agent; 2-aminoguanidine; metabisulfite;
D O I
10.1016/S0925-4439(00)00087-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The reaction of lens proteins with sugars over time results in the formation of protein-bound advanced glycation end products (AGEs). The most damaging element of AGE formation may be the synthesis of protein-protein cross-links in long-lived proteins, such as collagen or lens crystallins. A quantitative cross-linking assay, involving the sugar-dependent incorporation of [U-C-14]lysine into protein, was employed to determine the efficacy of a variety of potential cross-linking inhibitors. Reaction mixtures contained 5.0 mM L-threose, 2.5 mu Ci [C-14]lysine (1.0 mCi/mmole), 5.0 mg/ml bovine lens proteins, 0-10 mM inhibitor and 1.0 mM DTPA in 100 mM phosphate buffer, pH 7.0. Of 17 potential inhibitors tested, 11 showed 50% inhibition or less at 10 mM. The dicarbonyl-reactive compounds 2-aminoguanidine, semicarbazide and o-phenylenediamine inhibited 50% at 2.0 mM, whereas 10 mM dimethylguanidine had no effect. Several amino acids failed to compete effectively with [C-14]lysine in the cross-linking assay; however, cysteine inhibited 50% at 1.0 mM, This was likely due to the sulfhydryl group of cysteine, because 3-mercaptopropionic acid and reduced glutathione exhibited similar activity. Sodium metabisulfite had the highest activity, inhibiting 50% at only 0.1-0.2 mM. Protein dimer formation, as determined by SDS-PAGE, was inhibited in a quantitatively similar manner. The dicarbonyl-reactive inhibitors and the sulfur-containing compounds produced similar inhibition curves for [C-14]lysine incorporation over a 3 week assay with 250 mM glucose. A much lesser effect was observed on either the incorporation of [C-14]glucose, or on fluorophore formation (360/420 nm), suggesting that non-cross-link fluorophores were also formed. The inhibitor data were consistent with cross-linking by a dicarbonyl intermediate. This was supported by the fact that the inhibitors were uniformly less effective when the 5.0 mM threose was replaced by either 3.0 mM 3-deoxythreosone or 3.0 mM threosone. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:110 / 119
页数:10
相关论文
共 50 条
  • [21] Dietary protein intake and circulating advanced glycation end product/receptor for advanced glycation end product concentrations in the Health, Aging, and Body Composition Study
    Brinkley, Tina E.
    Semba, Richard D.
    Kritchevsky, Stephen B.
    Houston, Denise K.
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2020, 112 (06): : 1558 - 1565
  • [22] Clinical Potential of Advanced Glycation End-Product Inhibitors in Diabetes Mellitus
    Paolo Mené
    Francescaromana Festuccia
    Francesco Pugliese
    American Journal of Cardiovascular Drugs, 2003, 3 (5) : 315 - 320
  • [23] Inhibitors of advanced glycation end product formation and neurovascular dysfunction in experimental diabetes
    Cameron, NE
    Gibson, TM
    Nangle, MR
    Cotter, MA
    MAILLARD REACTION: CHEMISTRY AT THE INTERFACE OF NUTRITION, AGING, AND DISEASE, 2005, 1043 : 784 - 792
  • [24] Olive Leaf Extracts Are a Natural Source of Advanced Glycation End Product Inhibitors
    Kontogianni, Vassiliki G.
    Charisiadis, Pantelis
    Margianni, Evangelia
    Lamari, Fotini N.
    Gerothanassis, Ioannis P.
    Tzakos, Andreas G.
    JOURNAL OF MEDICINAL FOOD, 2013, 16 (09) : 817 - 822
  • [25] Clinical studies of advanced glycation end product inhibitors and diabetic kidney disease
    Williams M.E.
    Current Diabetes Reports, 2004, 4 (6) : 441 - 446
  • [26] Relation between early glycation product and advanced glycation end product on erythrocyte membrane protein and hemoglobin.
    Makita, Z
    Kuwajima, S
    Yanagisawa, K
    Atsumi, T
    Tsutida, K
    Obara, S
    Miyoshi, H
    Yoshioka, N
    Koike, T
    DIABETOLOGIA, 1997, 40 : 2320 - 2320
  • [27] Intra-molecular lysine-arginine derived advanced glycation end-product cross-linking in Type I collagen: A molecular dynamics simulation study
    Collier, Thomas A.
    Nash, Anthony
    Birch, Helen L.
    de Leeuw, Nora H.
    BIOPHYSICAL CHEMISTRY, 2016, 218 : 42 - 46
  • [29] PROTEIN - DNA CROSS-LINKING
    WELSH, J
    CANTOR, CR
    TRENDS IN BIOCHEMICAL SCIENCES, 1984, 9 (12) : 505 - 508
  • [30] PHOTODYNAMIC PROTEIN CROSS-LINKING
    VERWEIJ, H
    DUBBELMAN, TMAR
    VANSTEVENINCK, J
    BIOCHIMICA ET BIOPHYSICA ACTA, 1981, 647 (01) : 87 - 94